PDGFRB and breast carcinoma: A high expression of PDGFRb in the tumor stroma has been associated with unfavorable clinicopathological variables and shorter recurrence free and breast cancer specific survival, univariably, in a population-based cohort [11] although there are also studies which have failed to confirm the prognostic effect [12].